Document is current

Article History

First Online: 19 August 2020

Declarations

:

: This work was funded by Amgen Inc. Pharmerit International was commissioned by Amgen Inc. to carry out the systematic review (the design, data collection, analysis, and interpretation) and draft the manuscript.

: Michael Urbich, Gary Globe, and Heidi S. Wirtz are employees of Amgen and hold corporate stock in Amgen. Heidi S. Wirtz also holds corporate stock in Teva Pharmaceutical Industries Ltd. Krystallia Pantiri, Marieke Heisen, and Craig Bennison report funding from Amgen Inc. to Pharmerit International, during the conduct of the study; employment from Pharmerit International, outside the submitted work. Gian Luca Di Tanna was an employee of Amgen until February 2019. He received an honoraria fee from Amgen during the conduct of the study for providing methodological support.

: All data generated or analyzed during this study are included in this published article (and its supplementary information files).

: Not applicable.

: All authors adhered to the ICMJE authorship criteria. MU, GG, and GLDT planned this study. KP designed and conducted the review, screened the studies, and extracted the information. MU, GG, and GLDT participated in the review design, supervised the overall progress, and contributed to the interpretation of the results and revision of the manuscript. KP, MH, and CB were involved in the data analysis and interpretation, and initial drafting of the manuscript. All authors reviewed the subsequent drafts and provided comments and the final approval of the manuscript for submission.